O
Oki Suwarsa
Researcher at Padjadjaran University
Publications - 73
Citations - 217
Oki Suwarsa is an academic researcher from Padjadjaran University. The author has contributed to research in topics: Medicine & Leprosy. The author has an hindex of 6, co-authored 58 publications receiving 123 citations.
Papers
More filters
Journal ArticleDOI
Optimizing ultraviolet B radiation exposure to prevent vitamin D deficiency among pregnant women in the tropical zone: report from cohort study on vitamin D status and its impact during pregnancy in Indonesia
Raden Tina Dewi Judistiani,Sefita Aryuti Nirmala,Meilia Rahmawati,Reni Ghrahani,Yessika Adelwin Natalia,Adhi Kristianto Sugianli,Agnes Rengga Indrati,Oki Suwarsa,Budi Setiabudiawan +8 more
TL;DR: This study suggested that the best timing to get UVB exposure was between 10.00–13.00, with longer duration for women wearing hijab as compared to women without hijab, and duration of exposure to UVB should be longer for pregnant women using hijab.
Journal ArticleDOI
Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013.
TL;DR: The role of systemic corticosteroids in SJS and TEN are still controversial, but with a prompt and earlier treatment reduces mortality and improves outcomes of SJSand TEN patients.
Journal ArticleDOI
A clinician's reference guide for the management of atopic dermatitis in Asians
Steven K.W. Chow,Chew Swee Seow,Maria Victoria Dizon,Kiran Godse,Henry Foong,Vicheth Chan,Tran Hau Khang,Leihong Xiang,Syarief Hidayat,M. Yulianto Listiawan,Danang Triwahyudi,Srie Prihianti Gondokaryono,Endang Sutedja,Inne Arline Diana,Oki Suwarsa,Hartati Purbo Dharmadji,Agnes Sri Siswati,Retno Danarti,Retno Widowati Soebaryo,Windy Keumala Budianti +19 more
TL;DR: The management of AD among Asians requires a holistic approach, integrating evidence-based treatments while considering accessibility and cultural acceptability.
Journal ArticleDOI
Reactive perforating leprosy, erythema multiforme-like reactions, sweet's syndrome-like reactions as atypical clinical manifestations of Type 2 leprosy reaction.
TL;DR: The highlight of this case series was to report various atypical clinical manifestations of type 2 leprosy reaction such as reactive perforatingLeprosy, erythema multiforme-like reaction, and sweet's syndrome (SS)-like reaction.
Journal ArticleDOI
Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy.
Hendra Gunawan,Muljaningsih Sasmojo,Helena Eka Putri,Erda Avriyanti,Reti Hindritiani,Oki Suwarsa +5 more
TL;DR: Clinical pilot study concluded that 2,000 mg clarithromycin is as effective as 600 mg rifampicin in combination with dapsone and clofazimine regimen in MB leprosy patients, and can be considered as an alternative therapy for leproSy patients who resistance and/or allergy to rifampsicin.